BioSpace News Archive

Dizal Announces Pre-clinical and Clinical Results of Sunvozertinib (DZD9008) Published in Cancer Discovery

Dizal Pharmaceutical Co., Ltd (“Dizal”, SHEX: 688192) today announced the publication of the pre-clinical and early clinical data of sunvozertinib (DZD9008) for the treatment of non-small cell lung cancer with EGFR exon 20 insertion mutations in Cancer Discovery .

May 5, 2022
·
4 min read
Business

BioLineRx to Report First Quarter 2022 Results on May 11, 2022

BioLineRx Ltd. announced today it will release its unaudited financial results for the quarter ended March 31, 2022 on Wednesday, May 11, 2022 , before the US markets open.

May 5, 2022
·
2 min read
Herpes Simplex Virus (HSV) Vaccines Market Insights | Global Industry Analysis – Forecast [2020-2030]

Herpes simplex virus vaccines help preventing the occurrence of herpes disease. The disease can mainly occur around mouth or genitals, and also on different parts of the body.

May 5, 2022
·
6 min read
Pharnext: The Latest Findings From CMT&Me, a ‘Real-World’ Digital Lifestyle Study on Charcot-Marie-Tooth Diseases (‘CMTs’), to be Presented at the 2022 Peripheral Nerve Society (‘PNS’) Annual Meeting

Pharnext SA announces that new findings from CMT&Me, a ‘real-world’ digital lifestyle study in patients with Charcot-Marie-Tooth diseases, will be presented in three poster presentations at the upcoming Peripheral Nerve Society Annual Meeting.

May 5, 2022
·
3 min read
Biotech Bay

Mainz Biomed Provides Product Development Update on PancAlert

Mainz Biomed N.V. announced that PancAlert, its screening test candidate for pancreatic cancer has achieved multiple pre-clinical milestones that support the development of this potential first-in-class diagnostic for a deadly cancer indication.

May 5, 2022
·
6 min read
Biotech Bay

Annexon Biosciences to Participate in Upcoming May 2022 Investor Conferences

Annexon, Inc. announced that Douglas Love, Esq., president & chief executive officer, will participate in fireside chats during the following May investor conferences:

May 5, 2022
·
1 min read
Business

SpringWorks Therapeutics Reports First Quarter 2022 Financial Results and Recent Business Highlights

SpringWorks Therapeutics, Inc reported first quarter financial results for the period ended March 31, 2022 and provided an update on recent company developments.

May 5, 2022
·
10 min read
Business

Aeglea BioTherapeutics Reports First Quarter 2022 Financial Results and Provides Program Updates

Aeglea BioTherapeutics, Inc. announced financial results for the first quarter 2022 and provided program updates.

May 5, 2022
·
11 min read
Drug Development

Immunic Announces Start of Patient Cohorts in Its Phase 1 Clinical Trial of IMU-856 in Celiac Disease

Immunic, Inc. announced the start of the patient cohorts in its ongoing phase 1 clinical trial of IMU-856, the company’s third clinical asset, in patients with celiac disease.

May 5, 2022
·
9 min read
Business

InfuSystem Reports First Quarter 2022 Financial Results

InfuSystem Holdings, Inc., a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, reported financial results for the first quarter ended March 31, 2022.

May 5, 2022
·
21 min read